1. Home
  2. PCSA vs JDZG Comparison

PCSA vs JDZG Comparison

Compare PCSA & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Processa Pharmaceuticals Inc.

PCSA

Processa Pharmaceuticals Inc.

HOLD

Current Price

$2.79

Market Cap

8.2M

Sector

Health Care

ML Signal

HOLD

JDZG

JIADE LIMITED

HOLD

Current Price

$1.12

Market Cap

7.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCSA
JDZG
Founded
2011
2020
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
7.6M
IPO Year
2012
2023

Fundamental Metrics

Financial Performance
Metric
PCSA
JDZG
Price
$2.79
$1.12
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$25.00
N/A
AVG Volume (30 Days)
56.2K
554.0K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.07
52 Week High
$8.88
$4.06

Technical Indicators

Market Signals
Indicator
PCSA
JDZG
Relative Strength Index (RSI) 50.93 46.55
Support Level $1.96 $0.07
Resistance Level $3.26 $2.26
Average True Range (ATR) 0.36 0.16
MACD 0.00 -0.10
Stochastic Oscillator 31.78 4.09

Price Performance

Historical Comparison
PCSA
JDZG

About PCSA Processa Pharmaceuticals Inc.

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

About JDZG JIADE LIMITED

Jiade Ltd specializes in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platform and auxiliary solutions. Auxiliary solutions encompass exam administration services and teaching support services throughout the entire teaching cycle. Specifically, the company offers pre-enrollment guidance on school/major selection and application strategy development, training for entrance exams, and assistance in the application process. The company also provides offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance included in the one-stop comprehensive education supporting services in the People's Republic of China.

Share on Social Networks: